|$146,271||To support a working group of state health policy experts and stakeholders to examine emerging strategies for addressing the high cost of prescription drugs.||2016 - 2017||LJAF|
|$2,021,350||To support the launch of the Center for Prescription Drug Price Action.||2017 - 2020||LJAF|
|$3,684,731||To provide educational resources for prescription drug and commercial health care prices.||2019 - 2022||LJAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.